KatharineAmesNicholsonMD

Neurology • Boston, MA

Neuromuscular Medicine

Physician

Join to view full profile

Dr. Nicholson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nicholson's full profile

Already have an account?

Office
165 Cambridge St
Ste 600
Boston, MA 02114
Phone+1 617-726-4281

Education & Training

Massachusetts General HospitalFellowship, Clinical Research Fellowship in Neurodegenerative Disorders, focus on ALS, 2014 - 2015
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Neuromuscular Medicine (Neurology), 2013 - 2014
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Neurology, 2010 - 2013
George Washington University School of Medicine and Health SciencesClass of 2009

Certifications & Licensure

MA State Medical License 2013 - 2026
ME State Medical License 2021 - 2024
NH State Medical License 2022 - 2024
RI State Medical License 2022 - 2024
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Publications & Presentations

PubMed

45 citations
A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis.
Merit E Cudkowicz, Stacy R Lindborg, Namita A Goyal, Robert G Miller, Matthew J Burford
Muscle & Nerve. 2022-03-01
43 citations
Excessive release of inorganic polyphosphate by ALS/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons.
Cristian Arredondo, Carolina Cefaliello, Agnieszka Dyrda, Nur Jury, Pablo Martinez
Neuron. 2022-05-18
11 citations
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale.
Sheena Chew, Katherine Burke, Ella Collins, Reagan Church, Sabrina Paganoni
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2021-03-26

Press Mentions

Dosing Begins in Phase 2 Trial of AL001 in ALS with C9orf72 MutationsSeptember 13th, 2021
The Human Gut Microbiota in People with Amyotrophic Lateral SclerosisJune 15th, 2020